{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:48:37Z","timestamp":1793317717412,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":740,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1038\/s41379-020-00665-x","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T08:53:14Z","timestamp":1599727994000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"S1","title":["Diagnosis of ductal carcinoma in situ in an era of de-escalation of therapy"],"prefix":"10.1016","volume":"34","author":[{"given":"Stuart J.","family":"Schnitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-020-00665-x_bib1","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMra031301","article-title":"Ductal carcinoma in situ of the breast","volume":"350","author":"Burstein","year":"2004","journal-title":"N. Engl J Med."},{"key":"10.1038\/s41379-020-00665-x_bib2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/s41379-019-0204-1","article-title":"Ductal carcinoma in situ of the breast: an update for the pathologist in the era of individualized risk assessment and tailored therapies","volume":"32","author":"Hanna","year":"2019","journal-title":"Mod Pathol."},{"key":"10.1038\/s41379-020-00665-x_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-005-9101-z","article-title":"The natural history of ductal carcinoma in situ of the breast: a review","volume":"97","author":"Erbas","year":"2006","journal-title":"Breast Cancer Res Treat."},{"key":"10.1038\/s41379-020-00665-x_bib4","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/jnci\/djq099","article-title":"Overdiagnosis in cancer","volume":"102","author":"Welch","year":"2010","journal-title":"J Natl Cancer Inst."},{"key":"10.1038\/s41379-020-00665-x_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10549-018-4691-4","article-title":"The heterogeneity of cancer","volume":"169","author":"Welch","year":"2018","journal-title":"Breast Cancer Res Treat."},{"key":"10.1038\/s41379-020-00665-x_bib6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","article-title":"Ductal carcinoma in situ: to treat or not to treat, that is the question","volume":"121","author":"van Seijen","year":"2019","journal-title":"Br J Cancer."},{"key":"10.1038\/s41379-020-00665-x_bib7","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1200\/JCO.20.00124","article-title":"De-escalating treatment of low-risk breast ductal carcinoma in situ","volume":"38","author":"Lazzeroni","year":"2020","journal-title":"J Clin Oncol."},{"key":"10.1038\/s41379-020-00665-x_bib8","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1200\/JCO.19.02888","article-title":"De-escalation of locoregional therapy in low-risk disease for DCIS and early-stage invasive cancer","volume":"38","author":"Hwang","year":"2020","journal-title":"J Clin Oncol."},{"key":"10.1038\/s41379-020-00665-x_bib9","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/annonc\/mdx308","article-title":"De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017","volume":"28","author":"Curigliano","year":"2017","journal-title":"Ann Oncol."},{"key":"10.1038\/s41379-020-00665-x_bib10","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.breast.2017.06.019","article-title":"De-escalating and escalating systemic therapy of early breast cancer","volume":"34","author":"Smith","year":"2017","journal-title":"Breast."},{"key":"10.1038\/s41379-020-00665-x_bib11","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.breast.2017.06.018","article-title":"De-escalating and escalating surgery in the management of early breast cancer","volume":"34","author":"Morrow","year":"2017","journal-title":"Breast."},{"key":"10.1038\/s41379-020-00665-x_bib12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/tbj.13241","article-title":"Accelerated partial breast irradiation-redefining the treatment target for women with early stage breast cancer","volume":"25","author":"Shah","year":"2019","journal-title":"Breast J."},{"key":"10.1038\/s41379-020-00665-x_bib13","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1200\/JCO.20.00070","article-title":"Accelerated partial breast irradiation and intraoperative partial breast irradiation: reducing the burden of effective breast conservation","volume":"38","author":"White","year":"2020","journal-title":"J Clin Oncol."},{"key":"10.1038\/s41379-020-00665-x_bib14","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1093\/jnci\/djt256","article-title":"Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate?","volume":"105","author":"Punglia","year":"2013","journal-title":"J Natl Cancer Inst."},{"key":"10.1038\/s41379-020-00665-x_bib15","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.7326\/0003-4819-127-11-199712010-00014","article-title":"Using autopsy series to estimate the disease \u201creservoir\u201d for ductal carcinoma in situ of the breast: how much more breast cancer can we find?","volume":"127","author":"Welch","year":"1997","journal-title":"Ann Intern Med."},{"key":"10.1038\/s41379-020-00665-x_bib16","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.humpath.2013.02.015","article-title":"Incidental atypical proliferative lesions in reduction mammoplasty specimens: analysis of 2498 cases from 2 tertiary women's health centers","volume":"44","author":"Desouki","year":"2013","journal-title":"Hum Pathol."},{"key":"10.1038\/s41379-020-00665-x_bib17","first-page":"223","article-title":"Long-term follow-up of in situ carcinoma of the breast","volume":"11","author":"Eusebi","year":"1994","journal-title":"Semin Diagn Pathol."},{"key":"10.1038\/s41379-020-00665-x_bib18","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/modpathol.2014.141","article-title":"Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up","volume":"28","author":"Sanders","year":"2015","journal-title":"Mod Pathol."},{"key":"10.1038\/s41379-020-00665-x_bib19","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/1097-0142(19800815)46:4+<919::AID-CNCR2820461311>3.0.CO;2-Z","article-title":"The clinical significance of pre-invasive breast carcinoma","volume":"46","author":"Rosen","year":"1980","journal-title":"Cancer."},{"key":"10.1038\/s41379-020-00665-x_bib20","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/cncr.20979","article-title":"Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study","volume":"103","author":"Collins","year":"2005","journal-title":"Cancer."},{"key":"10.1038\/s41379-020-00665-x_bib21","doi-asserted-by":"crossref","DOI":"10.1007\/s11912-019-0777-3","article-title":"Management of ductal carcinoma in situ (DCIS) of the breast: present approaches and future directions","volume":"21","author":"Solin","year":"2019","journal-title":"Curr Oncol Rep."},{"key":"10.1038\/s41379-020-00665-x_bib22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jncimonographs\/lgq039","article-title":"Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast","volume":"2010","author":"Early Breast Cancer Trialists' Collaborative G","year":"2010","journal-title":"J Natl Cancer Inst Monogr."},{"key":"10.1038\/s41379-020-00665-x_bib23","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(99)05036-9","article-title":"Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial","volume":"353","author":"Fisher","year":"1999","journal-title":"Lancet."},{"key":"10.1038\/s41379-020-00665-x_bib24","first-page":"S36","article-title":"Estrogen receptor expression as a predictive marker of the effectiveness of tamoxifen in the treatment of DCIS: findings from NSABP Protocol B-24","volume":"76","author":"Allred","year":"2002","journal-title":"Breast Cancer Res Treat."},{"key":"10.1038\/s41379-020-00665-x_bib25","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0140-6736(15)01129-0","article-title":"Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial","volume":"387","author":"Forbes","year":"2016","journal-title":"Lancet."},{"key":"10.1038\/s41379-020-00665-x_bib26","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(15)01168-X","article-title":"Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial","volume":"387","author":"Margolese","year":"2016","journal-title":"Lancet."},{"key":"10.1038\/s41379-020-00665-x_bib27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10549-013-2813-6","article-title":"Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS)","volume":"143","author":"Wong","year":"2014","journal-title":"Breast Cancer Res Treat."},{"key":"10.1038\/s41379-020-00665-x_bib28","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1200\/JCO.2015.60.8588","article-title":"Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-Year results from the ECOG-ACRIN E5194 study","volume":"33","author":"Solin","year":"2015","journal-title":"J Clin Oncol."},{"key":"10.1038\/s41379-020-00665-x_bib29","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1200\/JCO.2014.57.9029","article-title":"RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation","volume":"33","author":"McCormick","year":"2015","journal-title":"J Clin Oncol."},{"key":"10.1038\/s41379-020-00665-x_bib30","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jnci\/djt067","article-title":"A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast","volume":"105","author":"Solin","year":"2013","journal-title":"J Natl Cancer Inst."},{"key":"10.1038\/s41379-020-00665-x_bib31","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-015-3464-6","article-title":"A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone","volume":"152","author":"Rakovitch","year":"2015","journal-title":"Breast Cancer Res Treat."},{"key":"10.1038\/s41379-020-00665-x_bib32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10549-018-4693-2","article-title":"Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies","volume":"169","author":"Rakovitch","year":"2018","journal-title":"Breast Cancer Res Treat."},{"key":"10.1038\/s41379-020-00665-x_bib33","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1158\/1078-0432.CCR-18-0842","article-title":"A biological signature for breast ductal carcinoma in situ to predict radiotherapy benefit and assess recurrence risk","volume":"24","author":"Bremer","year":"2018","journal-title":"Clin Cancer Res."},{"key":"10.1038\/s41379-020-00665-x_bib34","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1158\/1078-0432.CCR-19-1152","article-title":"Validation of a ductal carcinoma in situ biomarker profile for risk of recurrence after breast-conserving surgery with and without radiotherapy","volume":"26","author":"Weinmann","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-020-00665-x_bib35","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1245\/s10434-016-5596-2","article-title":"Active surveillance for DCIS: the importance of selection criteria and monitoring","volume":"23","author":"Grimm","year":"2016","journal-title":"Ann Surg Oncol."},{"key":"10.1038\/s41379-020-00665-x_bib36","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/jjco\/hyx059","article-title":"Current approach and future perspective for ductal carcinoma in situ of the breast","volume":"47","author":"Kanbayashi","year":"2017","journal-title":"Jpn J Clin Oncol."},{"key":"10.1038\/s41379-020-00665-x_bib37","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/s41379-019-0262-4","article-title":"Variability in diagnostic threshold for comedo necrosis among breast pathologists: implications for patient eligibility for active surveillance trials of ductal carcinoma in situ","volume":"32","author":"Harrison","year":"2019","journal-title":"Mod Pathol."},{"key":"10.1038\/s41379-020-00665-x_bib38","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1245\/s10434-016-5268-2","article-title":"Do LORIS trial eligibility criteria identify a ductal carcinoma in situ patient population at low risk of upgrade to invasive carcinoma?","volume":"23","author":"Pilewskie","year":"2016","journal-title":"Ann Surg Oncol."},{"key":"10.1038\/s41379-020-00665-x_bib39","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1245\/s10434-017-6018-9","article-title":"Surgical upstaging rates for vacuum assisted biopsy proven DCIS: implications for active surveillance trials","volume":"24","author":"Grimm","year":"2017","journal-title":"Ann Surg Oncol."},{"key":"10.1038\/s41379-020-00665-x_bib40","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1245\/s10434-017-5927-y","article-title":"A validated nomogram to predict upstaging of ductal carcinoma in situ to invasive disease","volume":"24","author":"Jakub","year":"2017","journal-title":"Ann Surg Oncol."},{"key":"10.1038\/s41379-020-00665-x_bib41","doi-asserted-by":"crossref","first-page":"712","DOI":"10.2214\/AJR.17.19244","article-title":"Patient selection for ductal carcinoma in situ observation trials: are the lesions truly low risk?","volume":"211","author":"Patel","year":"2018","journal-title":"AJR Am J Roentgenol."},{"key":"10.1038\/s41379-020-00665-x_bib42","unstructured":"Allison KH, Collins LC, Moriya T, Sanders ME, Visscher DW Atypical ductal hyperplasia. In: WHO Classfication of Tumours Editorial Board, editor. Breast Tumours. Lyon: IARC Press; 2019. p. 18\u201321."}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41379-020-00665-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-020-00665-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522200360X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522200360X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-020-00665-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:30:48Z","timestamp":1760229048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089339522200360X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":42,"alternative-id":["S089339522200360X"],"URL":"https:\/\/doi.org\/10.1038\/s41379-020-00665-x","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis of ductal carcinoma in situ in an era of de-escalation of therapy","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-020-00665-x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}